Trial Profile
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary)
- Indications Liver disorders
- Focus Pharmacokinetics
- Sponsors ApoPharma
- 30 Apr 2015 New trial record